Skip to main content
Equibles
TCRX logo

TCRX · TScan Therapeutics, Inc. · Analyst Estimates

Track TCRX — free

Use TCRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TCRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.32 +0.00 (+0.79%) At close · Sep 11
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“However, substantial doubt about the Company's ability to continue as a going concern exists. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Therefore, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”
View the 10-Q filed Aug 12, 2026
Market Cap
$21.72M
Shares
67.78M

Analyst Estimates

Compare analyst forecasts for TScan Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Source collection is delayed; the retained verified snapshot may not include newer publications.

Consensus not yet available

Source collection is delayed; the retained verified snapshot may not include newer publications.

Key facts CIK 1783328 CUSIP 89854M101 13F (30d) 26 filings 26 filers Visit website Investor relations